ZYTO Corp. Reports Record Second Quarter Results

LINDON, UT--(Marketwire - August 14, 2012) -

-- ZYTO Corp (OTCBB: ZYTC) (www.ZYTO.com).

ZYTO Corp, a Utah-based biotech company specializing in biocommunication applications, today reported net income of $31,270 for the second quarter of 2012, compared to a net loss of $66,238 for the same quarter last year, reflecting an increase of $97,508. Total revenues for the second quarter of 2012 increased 18.9% to $1.4 million from $1.18 million in the same quarter last year.

The Company also reported net income of $96,854 for the six months ended June 30, 2012, compared to a net loss of $397,390 for the same period last year, reflecting an increase of $494,244.

“We are delighted to report another quarter of strong momentum as demonstrated by an increase of $222,609 increase in sales over the same period last year,” said Chairman and Chief Executive Officer, Dr. Vaughn R Cook. “We are fully focused on enhancing our products and expanding our customer base. We continue to build our solid position in the market and improve our customer focus, thereby achieving a steady improvement in our financial performance.”

“We are excited to report an increase in net income of almost $500,000 compared to the six months ended June 30, 2011,” said Brian E. Halladay, Chief Financial Officer. “We’re continuing to invest in our cutting-edge products and services which will drive our business forward.”

About ZYTO Corp

ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer biocommunication technology to facilitate decision making about healthcare and wellness options.

For more information and to receive a copy of the Company’s Quarterly Report, visit www.ZYTO.com or contact their Headquarters at 801-224-7199.

Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO’s marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO’s stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company’s products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company’s periodic reports filed with the U.S. Securities and Exchange Commission. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.